Ingredient

A mixture of: Disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate, and trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl) penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate

⚠ EU Restricted

Identification

EINECS / EC 402-660-9
CosIng Ref 29374

Function & Classification

EU Regulatory Status

🇪🇺
⚠ Restricted — EU Reg. 1223/2009 II

Safety Profile

No toxicology data available yet for this ingredient.

Check SCCS opinions or CIR reports for published safety assessments.

NOAEL · Dermal Absorption % · Sensitization

Formulation Guidelines

Usage level, pH range, solubility and addition phase not yet available.

Usage Level % · Addition Phase · Solubility

Suppliers & Documents

No verified suppliers listed for this ingredient yet.

Are you a supplier of A mixture of: Disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate, and trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl) penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate? Register as a supplier to add your listing and upload TDS & SDS documents.

Documents

External Resources